Skip to main content
Patient Care
Please review our updated visitor policy and learn more about the updated in-person patient experience. If you have concerns or are experiencing any symptoms, you can schedule a Video Visit immediately or access our Digital Health Services at any time. For more information about COVID-19 review the patient guide or call our hotline at (646) 697-4000. Due to the Governor's recent travel regulations, kindly inform our staff of any recent travel to one of the quarantine states prior to any in person visits.
Patient Care
You are here

The NewYork-Presbyterian Weill Cornell Transplant program, in cooperation with the Rogosin Institute, was the first kidney transplant program established in New York State, now more than five decades ago.

Since that time, over 5,000 kidney transplants have been performed. With approximately 200 kidney transplants performed each year since 2006, our program is among the largest in the country offering the very latest transplant management protocols and surgical interventions.

Our transplant center’s patient and graft survival rates are excellent, which is especially notable given our diverse and often complicated patient population. Transplant outcomes are calculated by the Scientific Registry of Transplant Recipients (SRTR) based on the mix of recipient and donor characteristics at our center compared with experience with similar patients throughout the country.

Photo celebrating the division's 50th anniversary.

Molecular tools developed at Weill Cornell Medicine allow us, for the first time in the history of kidney transplantation, to individualize the medication regimen used to suppress the immune system. At the same time, these tools reduce the amount of exposure to these medications.

Since 2001, approximately 75 percent of our kidney transplant patients have received a steroid-sparing medication regimen and over 2,000 transplanted patients are completely off of steroids.